TFEB and neuroblastoma: Moreover, because modifications of GSL content and plasma membrane-associated glycohydrolase activity are often associated with neurodegenerative disorders [25,26], the effect of C1 treatment on both TFEB activation and transport of glycohydrolases to the plasma membrane was also investigated on the neuroblastoma cell line SH-SY5Y.